TrialJournal of veterinary internal medicine2018

Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study.

A Boswood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.